1. Accelerating Patients’ Access to Advanced Therapies in the EU
Ahmed Elsanhoury, Ralf Sanzenbacher, Petra Reinke, Mohamed Abou-El-Enein 
Molecular Therapy - Methods & Clinical Development 
Volume 7, Pages (December 2017)
DOI: /j.omtm
Copyright © 2017 The Author(s) Terms and Conditions

2. Figure 1 Expedited and Exceptional Authorization Schemes in the EU
1The amount of therapeutic data available at the time of application submission is decreasing from the left to the right side of the scheme.
2PRIME-designated products are eligible to accelerated assessment.
Molecular Therapy - Methods & Clinical Development 2017 7, 15-19DOI: ( /j.omtm )
Copyright © 2017 The Author(s) Terms and Conditions